Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
First Claim
Patent Images
1. A method of detecting a molecule of interest, the method comprising:
- providing a first molecule covalently bonded to at least one magnetizable nanoparticle;
providing a second molecule covalently bonded to a substrate;
contacting the first molecule to the second molecule under conditions suitable for selective binding of the first molecule to the second molecule to form a complex; and
detecting the complex.
2 Assignments
0 Petitions
Accused Products
Abstract
Magnetic nanoparticles and methods for their use in detecting biological molecules are disclosed. The magnetic nanoparticles can be attached to nucleic acid molecules, which are then captured by a complementary sequence attached to a detector, such as a spin valve detector or a magnetic tunnel junction detector. The detection of the bound magnetic nanoparticle can be achieved with high specificity and sensitivity.
113 Citations
47 Claims
-
1. A method of detecting a molecule of interest, the method comprising:
-
providing a first molecule covalently bonded to at least one magnetizable nanoparticle;
providing a second molecule covalently bonded to a substrate;
contacting the first molecule to the second molecule under conditions suitable for selective binding of the first molecule to the second molecule to form a complex; and
detecting the complex. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
-
-
20. A spin valve detector array useful for the detection of magnetic nanoparticles, the detector array comprising a plurality of detection sites;
- wherein;
each of the plurality of detection sites comprise;
a first ferromagnetic layer;
a non-magnetic layer facially contacting the first ferromagnetic layer;
a second ferromagnetic layer facially contacting the non-magnetic layer;
a passivation layer facially contacting the second ferromagnetic layer; and
a binding molecule covalently bonded to the passivation layer; and
the binding molecule is selected from the group consisting of a nucleic acid, natural or synthetic DNA, natural or synthetic RNA, a peptide, a protein, an antibody, a lipid, a virus, a polymer, a toxin compound, a pharmaceutical compound, a biohazard compound, and an explosive compound. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28)
- wherein;
-
29. A magnetic tunnel junction (MTJ) detector array useful for the detection of magnetic nanoparticles, the detector array comprising a plurality of detection sites;
- wherein;
each of the plurality of detection sites comprise;
a bottom electrode;
a plurality of magnetic layers contacting the bottom electrode;
a tunnel barrier contacting at least one of the plurality of magnetic layers;
a ferromagnetic layer (the second magnetic layer) on the top of the tunnel barrier;
a gold layer contacting the second magnetic layer;
a conductive layer, typically with an aperture exposing part of the gold covered MTJ, contacting the gold layer; and
a binding molecule covalently bonded to the gold layer, and the binding molecule is selected from the group consisting of a nucleic acid, natural or synthetic DNA, natural or synthetic RNA, a peptide, a protein, an antibody, a lipid, a virus, a polymer, a toxin compound, a pharmaceutical compound, a biohazard compound, and an explosive compound. - View Dependent Claims (30, 31, 32, 33, 34, 35, 36)
- wherein;
-
37. An antiferromagnetically coupled magnetic nanoparticle comprising two or more ferromagnetic layers and a covalently bonded target molecule, wherein:
-
the ferromagnetic layers comprise FexCo1-x (x is about 0.5 to about 0.7), Co, Co alloys, ferrite, Cobalt nitride, Cobalt oxide, Co—
Pd, Co—
Pt, Iron, Iron alloys, Fe—
Au, Fe—
Cr, Fe—
N, Fe3O4, Fe—
Pd, Fe—
Pt, Fe—
Zr—
Nb—
B, Mn—
N, Nd—
Fe—
B, Nd—
Fe—
B—
Nb—
Cu, Ni, Ni alloys, or mixtures thereof; and
the target molecule is a nucleic acid, DNA, RNA, a peptide, a protein, an antibody, a lipid, a virus, a polymer, a toxin compound, a drug compound, a biohazard compound, or an explosive compound. - View Dependent Claims (38, 39, 40, 41, 42, 43, 44, 45)
-
-
46. A method of preparing an antiferromagnetically coupled magnetic nanoparticle conjugate, the method comprising:
-
providing an antiferromagnetically coupled magnetic nanoparticle comprising a gold surface layer or a glass surface layer;
providing a target molecule selected from the group consisting of a nucleic acid, DNA, RNA, a peptide, a protein, an antibody, a lipid, a virus, a polymer, a toxin compound, a pharmaceutical compound, a biohazard compound, and an explosive compound; and
contacting the nanoparticle and the target molecule under conditions suitable for the formation of a covalently bonded nanoparticle-target molecule conjugate. - View Dependent Claims (47)
-
Specification